Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma

NCT05333302 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia
Lymphoblastic B-Cell Lymphoma

Interventions

BIOLOGICAL: CD19 CAR-T-cells
DRUG: Tocilizumab

Sponsor

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology